PubRank

L Rozendaal

Author PubWeight™ 45.89‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial. Lancet 2007 5.81
2 Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet 1999 4.24
3 The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. Int J Cancer 1995 3.29
4 Urogenital Chlamydia trachomatis serovars in men and women with a symptomatic or asymptomatic infection: an association with clinical manifestations? J Clin Microbiol 2000 1.58
5 Cytological regression and clearance of high-risk human papillomavirus in women with an abnormal cervical smear. Lancet 2001 1.56
6 The Dutch CISOE-A framework for cytology reporting increases efficacy of screening upon standardisation since 1996. J Clin Pathol 2004 1.55
7 HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications. Br J Cancer 2012 1.53
8 Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands. Br J Cancer 2006 1.43
9 [Condylomata acuminata: a rare symptom of ubiquitous human papilloma virus and not a sign of risky sex behavior]. Ned Tijdschr Geneeskd 1999 1.40
10 Primary screening for high risk HPV by home obtained cervicovaginal lavage is an alternative screening tool for unscreened women. J Clin Pathol 2002 1.36
11 High-risk HPV type-specific clearance rates in cervical screening. Br J Cancer 2007 1.24
12 HPV prevalence in cytomorphologically normal cervical scrapes of pregnant women as determined by PCR: the age-related pattern. J Med Virol 1995 1.18
13 Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intraepithelial neoplasia. Br J Cancer 2001 1.15
14 HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears. Br J Cancer 2001 1.14
15 Long-term protective effect of high-risk human papillomavirus testing in population-based cervical screening. Br J Cancer 2005 1.12
16 High-risk HPV testing in women with borderline and mild dyskaryosis: long-term follow-up data and clinical relevance. J Pathol 2001 1.12
17 Marfan syndrome in children and adolescents: predictive and prognostic value of aortic root growth for screening for aortic complications. Heart 1998 1.10
18 HPV testing and monitoring of women after treatment of CIN 3: review of the literature and meta-analysis. Obstet Gynecol Surv 2004 1.10
19 HPV typing and testing in gynaecological pathology: has the time come? Histopathology 1998 1.06
20 Variable phenotypes associated with 10q23 microdeletions involving the PTEN and BMPR1A genes. Clin Genet 2008 1.03
21 High risk human papillomavirus in women with normal cervical cytology prior to the development of abnormal cytology and colposcopy. BJOG 2000 0.99
22 Comparison of GP5+/6+-PCR and SPF10-line blot assays for detection of high-risk human papillomavirus in samples from women with normal cytology results who develop grade 3 cervical intraepithelial neoplasia. J Clin Microbiol 2008 0.96
23 High-risk human papillomavirus clearance in pregnant women: trends for lower clearance during pregnancy with a catch-up postpartum. Br J Cancer 2002 0.90
24 The contribution of HPV18 to cervical cancer is underestimated using high-grade CIN as a measure of screening efficiency. Br J Cancer 2007 0.88
25 Comparison of Hybrid capture 2 testing at different thresholds with cytology as primary cervical screening test. Br J Cancer 2010 0.88
26 Incidence and survival rate of women with cervical cancer in the Greater Amsterdam area. Br J Cancer 2003 0.87
27 Cytology history preceding cervical cancer diagnosis: a regional analysis of 286 cases. Br J Cancer 2011 0.81
28 [Human papillomavirus and screening for cervical cancer: state of art and prospects]. Ned Tijdschr Geneeskd 2000 0.78
29 Implementation of human papillomavirus testing in cervical screening without a concomitant decrease in participation rate. J Clin Pathol 2006 0.78
30 A predictive role for noncancerous prostate cells: low connexin-26 expression in radical prostatectomy tissues predicts metastasis. Br J Cancer 2012 0.78
31 High-risk human papillomavirus is present in cytologically false-negative smears: an analysis of "normal" smears preceding CIN2/3. J Clin Pathol 2007 0.78
32 Extended duration of the detectable stage by adding HPV test in cervical cancer screening. Br J Cancer 2003 0.77
33 Digital color imaging colposcopy: a matter of choice. Eur J Obstet Gynecol Reprod Biol 1998 0.77
34 HrHPV-testing in a university hospital gynecology outpatient clinic: recommendations for clinical practice. Gynecol Oncol 2011 0.75